RecruitingNCT06984965
Role of EEG in Differentiation Between Ischemic and Hemorrhagic Stroke
Role of Electroencephalogram (EEG) in Differentiation Between Ischemic and Hemorrhagic Stroke and as a Predictor of Post-stroke Recovery
Sponsor
Assiut University
Enrollment
300 participants
Start Date
Jun 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
Searching electrical activity registered by EEG in acute ischemic and hemorrhagic stroke and comparing these parameters to the poststroke recovery patterns to investigate the role of EEG as a differentiation tool and as a predictor of post-stroke recovery.
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria7
- Age above 18 and below 80 years.
- Acute Ischemic stroke: ischemic arteria cerebri media infarct confirmed by MRI.
- Acute Hemorrhagic stroke: spontaneous intraparenchymal bleeding confirmed by CT.
- Stroke onset <72 hours before expected time of performing EEG.
- First-ever ischemic stroke.
- Measurable deficit on the National Institute of Health Stroke Scale (NIHSS).
- Able to give and sign informed consent.
Exclusion Criteria17
- Transient Ischemic Attacks (TIAs).
- Greater than 72 hours past the initial insult.
- Patients with subarachnoid haemorrhage, traumatic haemorrhage (epidural/subdural bleeding), cerebral venous sinus thrombosis, indication for urgent neurosurgical intervention.
- History of other central nervous system diseases.
- Any signs unfit for MRI/EEG scan.
- Injury or active infection of electrode cap placement area.
- Claustrophobia; recognition disorder.
- Known skull defect or head trauma.
- Previous neurological procedure (metallic implant, brain pace, cranial operation history).
- Significant physical impairment that would restrict the ability to use the portable EEG devices.
- Presence of malignancy or systemic rheumatic disease
- Non-stroke disease or lesion affecting the sensorimotor system.
- Alcohol or drug addiction.
- Presence of pump/shunt.
- Presence of Malignancy.
- Presence of severe cognitive impairment.
- History of epilepsy or taking medication due to epilepsy.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06984965
Related Trials
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
NCT0568664228 locations
Radial Versus Femoral Access For Thrombectomy in Patients With Acute Basilar Artery Occlusion
NCT059035601 location
Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke
NCT064407073 locations
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
NCT07361302224 locations
Endovascular Therapy Versus Best Medical Treatment for Acute Large Vessel Occlusion Stroke With Low NIHSS
NCT061434881 location